BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors
Clinical trial NCT00095459 · COMPLETED
Trial details
- NCT number
- NCT00095459
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-02
- Primary completion
- 2005-11-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.